US20020142020A1 - Biocidal organic acid salts of a polymeric biguanide - Google Patents
Biocidal organic acid salts of a polymeric biguanide Download PDFInfo
- Publication number
- US20020142020A1 US20020142020A1 US09/445,765 US44576599A US2002142020A1 US 20020142020 A1 US20020142020 A1 US 20020142020A1 US 44576599 A US44576599 A US 44576599A US 2002142020 A1 US2002142020 A1 US 2002142020A1
- Authority
- US
- United States
- Prior art keywords
- composition
- carbon atoms
- organic acid
- polymeric biguanide
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229940123208 Biguanide Drugs 0.000 title claims abstract description 36
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 title claims abstract description 32
- -1 organic acid salts Chemical class 0.000 title description 12
- 230000003115 biocidal effect Effects 0.000 title description 2
- 239000000203 mixture Substances 0.000 claims abstract description 35
- 150000007524 organic acids Chemical class 0.000 claims abstract description 25
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 24
- 150000003839 salts Chemical class 0.000 claims abstract description 24
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000007788 liquid Substances 0.000 claims description 25
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 claims description 9
- 230000002906 microbiologic effect Effects 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 7
- 125000001931 aliphatic group Chemical group 0.000 claims description 6
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 6
- 125000001424 substituent group Chemical group 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 5
- 239000012458 free base Substances 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 235000021355 Stearic acid Nutrition 0.000 claims description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid group Chemical group C(CCCCC)(=O)O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 3
- 239000008117 stearic acid Substances 0.000 claims description 3
- 150000007513 acids Chemical class 0.000 claims description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 2
- 125000002843 carboxylic acid group Chemical group 0.000 claims description 2
- 150000008282 halocarbons Chemical class 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 2
- VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Polymers CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 abstract description 10
- 150000004283 biguanides Chemical class 0.000 description 24
- 229920002413 Polyhexanide Polymers 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 229920006395 saturated elastomer Polymers 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 0 C*NC(=N)NC(=N)N[Y]NC(=N)NC(=N)NC Chemical compound C*NC(=N)NC(=N)N[Y]NC(=N)NC(=N)NC 0.000 description 5
- 125000001183 hydrocarbyl group Chemical group 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 4
- 125000004122 cyclic group Chemical group 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- XVWNRRBDNKYCRS-UHFFFAOYSA-N CCCCCCCNC(=N)NC(=N)NC Chemical compound CCCCCCCNC(=N)NC(=N)NC XVWNRRBDNKYCRS-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 150000002334 glycols Chemical class 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- HXVNBWAKAOHACI-UHFFFAOYSA-N 2,4-dimethyl-3-pentanone Chemical compound CC(C)C(=O)C(C)C HXVNBWAKAOHACI-UHFFFAOYSA-N 0.000 description 2
- CCTFMNIEFHGTDU-UHFFFAOYSA-N 3-methoxypropyl acetate Chemical compound COCCCOC(C)=O CCTFMNIEFHGTDU-UHFFFAOYSA-N 0.000 description 2
- FFWSICBKRCICMR-UHFFFAOYSA-N 5-methyl-2-hexanone Chemical compound CC(C)CCC(C)=O FFWSICBKRCICMR-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 239000005864 Sulphur Substances 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- CATSNJVOTSVZJV-UHFFFAOYSA-N heptan-2-one Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 1
- PTTPXKJBFFKCEK-UHFFFAOYSA-N 2-Methyl-4-heptanone Chemical compound CC(C)CC(=O)CC(C)C PTTPXKJBFFKCEK-UHFFFAOYSA-N 0.000 description 1
- NQBXSWAWVZHKBZ-UHFFFAOYSA-N 2-butoxyethyl acetate Chemical compound CCCCOCCOC(C)=O NQBXSWAWVZHKBZ-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- 229940093475 2-ethoxyethanol Drugs 0.000 description 1
- SVONRAPFKPVNKG-UHFFFAOYSA-N 2-ethoxyethyl acetate Chemical compound CCOCCOC(C)=O SVONRAPFKPVNKG-UHFFFAOYSA-N 0.000 description 1
- VXKUOGVOWWPRNM-UHFFFAOYSA-N 3-ethoxypropyl acetate Chemical compound CCOCCCOC(C)=O VXKUOGVOWWPRNM-UHFFFAOYSA-N 0.000 description 1
- YEHVMOSEQXQFJE-UHFFFAOYSA-N 6-ethoxyhexan-3-ol Chemical compound CCOCCCC(O)CC YEHVMOSEQXQFJE-UHFFFAOYSA-N 0.000 description 1
- ONRLJIQIPPJCSQ-UHFFFAOYSA-N 6-methoxyhexan-3-ol Chemical compound CCC(O)CCCOC ONRLJIQIPPJCSQ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- RWQSPTCDMUFYCO-UHFFFAOYSA-N CC(O)=O.CC(O)=O.C1=CC(CC(CC)CCCC)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(CC(CC)CCCC)C=C1 Chemical compound CC(O)=O.CC(O)=O.C1=CC(CC(CC)CCCC)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(CC(CC)CCCC)C=C1 RWQSPTCDMUFYCO-UHFFFAOYSA-N 0.000 description 1
- KFRKYGDKXYZXHK-UHFFFAOYSA-N CCCCC(=N)NC(=N)NC1=CC=C(Cl)C=C1.CCCCC(=N)NC(=N)NCC(CC)CCCC Chemical compound CCCCC(=N)NC(=N)NC1=CC=C(Cl)C=C1.CCCCC(=N)NC(=N)NCC(CC)CCCC KFRKYGDKXYZXHK-UHFFFAOYSA-N 0.000 description 1
- SIQWQBQGWREFSE-UHFFFAOYSA-N CNC(=N)NC#N Chemical compound CNC(=N)NC#N SIQWQBQGWREFSE-UHFFFAOYSA-N 0.000 description 1
- AKWJBSDLSFROSK-UHFFFAOYSA-N CNC(=N)NC(=N)NC Chemical compound CNC(=N)NC(=N)NC AKWJBSDLSFROSK-UHFFFAOYSA-N 0.000 description 1
- BEJVYQMMUBTMBA-UHFFFAOYSA-N CNCOC1CCCCC1OCNC Chemical compound CNCOC1CCCCC1OCNC BEJVYQMMUBTMBA-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- LFVVNPBBFUSSHL-UHFFFAOYSA-N alexidine Chemical compound CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC LFVVNPBBFUSSHL-UHFFFAOYSA-N 0.000 description 1
- 229950010221 alexidine Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-M behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC([O-])=O UKMSUNONTOPOIO-UHFFFAOYSA-M 0.000 description 1
- 229940116224 behenate Drugs 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 150000004287 bisbiguanides Chemical class 0.000 description 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 150000004292 cyclic ethers Chemical class 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 150000001983 dialkylethers Chemical group 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000005555 metalworking Methods 0.000 description 1
- 229940017219 methyl propionate Drugs 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003750 molluscacide Substances 0.000 description 1
- 230000002013 molluscicidal effect Effects 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
- A01N47/42—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=CX2 groups, e.g. isothiourea
- A01N47/44—Guanidine; Derivatives thereof
Definitions
- the present invention relates to organic acid salts of polymeric biguanides, to compositions thereof, and their use as an industrial biocide or in personal care applications.
- PHMB Poly(hexamethylenebiguanide)
- Behenic acid is an aliphatic carboxylic acid containing a C 21 -alkyl chain and falls within the group, anionic surfactants.
- the concentrated aqueous solution of PHMB in the form of its hydrochloride salt is clearly stated to be incompatible with anionic surfactants, alkyl sulphonates and anionic caramels as disclosed in the Product Information Notes for Vantocil IB (37-8E dated Jun. 1, 1994) and Cosmocil CQ (37-26E dated Apr. 1, 1994). Both Vantocil and Cosmocil are registered trade marks of Zeneca Specialties.
- Bisbiguanides have also been made available commercially as water-soluble salts such as chlorhexidine (1,1′-hexamethylene bis[5-(4-chlorophenyl)-biguanide]digluconate) and alexidine (1,1′-hexamethylene bis [5-(4-(2-ethylhexyl)phenyl)-biguanide]-diacetate).
- water-soluble salts and PHMB hydrochloride are not particularly suited to provide a solution of the polymeric biguanide in organic liquids, especially non-polar organic liquids.
- PHMB in the form of its salt of an organic acid containing from 4 to 30 carbon atoms exhibits high antimicrobial, especially antibacterial activity, and that such salts exhibit increased solubility in organic media, especially organic liquids.
- composition comprising a carrier and a polymeric biguanide in the form of its salt with an organic acid containing from 4 to 30 carbon atoms, including mixtures thereof.
- the polymeric biguanide contains at least one biguanide unit of Formula 1.
- the polymeric biguanide contains at least two biguanide units of Formula 1 which are linked by a bridging group which contains at least one methylene group.
- the bridging group may include a polymethylene chain which may optionally be interrupted by hetero atoms such as oxygen, sulphur or nitrogen.
- the bridging group may include one or more cyclic nuclei which may be saturated or unsaturated.
- the bridging group is such that there are at least three, and especially at least four, carbon atoms directly interposed between two adjacent biguanide units of Formula 1.
- the polymeric biguanide may be terminated by any suitable group which may be a hydrocarbyl or substituted hydrocarbyl group or an amine or a group
- the terminating group is a hydrocarbyl group, it may be alkyl, cycloalkyl or aralkyl.
- the substituent may be any substituent that does not exhibit an undesirable adverse effect on the microbiological properties of the polymeric biguanide.
- substituents or substituted hydrocarbyl groups are aryloxy, alkoxy, acyl, acyloxy, halogen and nitrile.
- the polymeric biguanide contains two biguanide groups of Formula 1
- the two biguanide units are preferably linked by a polymethylene group, especially a hexamethylene group.
- the terminating groups in such polymeric biguanides are preferably 4-chlorophenyl or 2-ethylhexyl. Examples of such compounds are represented by Formulae 2 and 3 in their free base form
- the polymeric biguanide preferably contains more than two biguanide units of Formula 1 and preferably is a linear polymeric biguanide which has a recurring polymeric unit represented by Formula 4
- X and Y may be the same or different and represent bridging groups in which, together, the total number of carbon atoms directly interposed between the pairs of nitrogen atoms linked by X and Y is not less than 9 and not greater than 17.
- the bridging groups X and Y may consist of a polymethylene chain, optionally interrupted by a heteroatom such as oxygen, sulphur or nitrogen.
- X and Y may also incorporate a cyclic nucleus which may be saturated or unsaturated, wherein the number of carbon atoms directly interposed between the pairs of nitrogen atoms linked by X and Y is taken as including that segment of the cyclic group, or groups, which is the shortest.
- the preferred polymeric biguanide for use in the present invention is poly(hexamethylenebiguanide), in which both X and Y in Formula 4 are the group —(CH 2 ) 6 +
- the polymeric biguanides of Formula 4 are typically obtained as mixtures of polymers in which the polymer chains are of different lengths. Preferably, the number of individual biguanide units
- [0018] is, together, from 3 to about 80.
- n is from 4 to 40 and especially from 4 to 15. It is particularly preferred that the average value of n in the mixture is 12. Preferably, the average molecular weight of the polymer mixture is from 1100 to 3300.
- the organic acid which forms the salt with the polymeric biguanide may contain a phosphonic, phosphoric, sulphonic or sulphate group but preferably contains a carboxylic acid group.
- the organic acid may be aromatic but is preferably aliphatic, including alicyclic.
- the aliphatic chain of the organic acid may be linear or branched, saturated or unsaturated, including mixtures thereof.
- the aliphatic chain is linear and it is also preferred that the organic acid is an aliphatic carboxylic acid.
- the organic acid contains not less than eight, more preferably not less than ten and especially not less than twelve carbon atoms excluding the acid group.
- the organic acid contains not greater than 24, more preferably not greater than 20 and especially not greater than 18 carbon atoms excluding the acid group.
- the organic acid may contain more than one acid group but it is preferred that only one such group is present.
- the organic acid may be substituted by a halogen or particularly hydroxy group. It is, however, preferred that the organic acid is free from substituents.
- aliphatic carboxylic acids are available commercially as mixtures such as those obtained from animal fats and vegetable oils and these contain both saturated and unsaturated aliphatic chains. These have also been found useful, especially the C 14-18 -alkyl carboxylic acids and their fully saturated or hydrogenated analogues.
- Examples of optionally substituted carboxylic acids are valeric, hexanoic, octanoic, 2-octenoic, lauric, 5-dodecenoic, myristic, pentadecanoic, palmitic, oleic, stearic, eicosanoic, heptadecanoic, palmitoleic, ricinoleic, 1 2-hydroxystearic, 16-hydroxyhexadecanoic, 2-hydroxycaproic, 1 2-hydroxydodecanoic, 5-hydroxydodecanoic, 5-hydroxydecanoic, 4-hydroxydecanoic, dodecanedioic, undecanedioic, sebacic, benzoic, hydroxbenzoic and teraphthalic acids.
- the carrier may be a solid but is preferably a liquid.
- the liquid may be water whereby the composition containing the organic acid is a dispersion or emulsion.
- the aqueous composition also contains a surfactant, particularly a non-ionic surfactant such as a polyalkylene oxide and especially an ethoxylate.
- the aqueous composition may also contain other adjuvents which help distribute the polymeric biguanide salt uniformly throughout the composition. Examples of such adjuvants are compounds which provide structure to the water to inhibit sedimentation such as alginates and gums, particularly Xanthan gum.
- the carrier is a liquid it is preferably a polar organic liquid, a substantially non-polar organic liquid or a halogenated hydrocarbon.
- polar in relation to the organic liquid is meant an organic liquid or resin capable of forming moderate to strong bonds as described in the article entitled “A Three Dimensional Approach to Solubility” by Crowley et al in Journal of Paint Technology, Vol. 38, 1966, at page 269.
- Such organic liquids generally have a hydrogen bonding number of 5 or more as defined in the abovementioned article.
- Suitable polar organic liquids are amines, ethers, especially lower alkyl ethers, organic acids, esters, ketones, glycols, alcohols and amides. Numerous specific examples of such moderately strongly hydrogen bonding liquids are given in the book entitled “Compatibility and Solubility” by Ibert Mellan (published in 1968 by Noyes Development Corporation) in Table 2.14 on pages 3940 and these liquids all fall within the scope of the term polar organic liquid as used herein.
- Preferred polar organic liquids are dialkyl ketones, alkyl esters of alkane carboxylic acids and alkanols, especially such liquids containing up to, and including, a total of 6 carbon atoms.
- dialkyl and cycloalkyl ketones such as acetone, methyl ethyl ketone, diethyl ketone, di-isopropyl ketone, methyl isobutyl ketone, di-isobutyl ketone, methyl isoamyl ketone, methyl n-amyl ketone and cyclohexanone
- alkyl esters such as methyl acetate, ethyl acetate, isopropyl acetate, butyl acetate, ethyl formate, methyl propionate, methoxy propylacetate and ethyl butyrate
- the substantially non-polar, organic liquids which may be used, either alone or in admixture with the aforementioned polar liquids, are aliphatic and aromatic hydrocarbons, such as toluene and xylene, and halogenated aliphatic and aromatic hydrocarbons, such as trichloro-ethylene, perchloroethylene and chlorobenzene.
- the organic acid salt of the polymeric biguanide may be made by any method known to the art but is preferably made by precipitation of the biguanide from aqueous solution by addition of the organic acid under alkaline conditions.
- the organic acid salts of the biguanide may be further purified by dissolution in a suitable organic liquid which is preferably immiscible with water and washing the organic phase with water to remove any residual water soluble salts.
- the amount of polymeric biguanide in the composition may vary between wide limits depending on its end usage. Thus, where the composition is used to confer antimicrobial protection to a medium which is to be protected against microbiological spoilage the amount of polymeric biguanide may be just sufficient to provide such protection.
- the amount of biguanide is not less than 1 ppm, more preferably not less than 10 ppm and especially not less than 20 ppm. It will be appreciated that where the composition containing the salt of the polymeric biguanide is to be transported in bulk the amount of the polymeric biguanide salt is as high as possible provided that the biguanide salt remains uniformly distributed throughout the composition.
- the amount of polymeric biguanide salt in the composition is not greater than 30%, more preferably not greater than 25% and especially not greater than 20% based on the total weight of the composition.
- polymeric biguanides in the form of a salt with an organic acid containing from 4 to 30 carbon atoms are novel.
- a polymeric biguanide in the form of a salt with an aliphatic carboxylic acid containing from 4 to 20 carbon atoms, particularly from 10 to 20 carbon atoms and especially from 12 to 18 carbon atoms excluding the —COOH group, optionally substituted by hydroxy is provided.
- the aliphatic carboxylic acid is free from substituents.
- the aliphatic carboxylic acid may be linear or branched, saturated or unsaturated, including mixtures thereof. It is preferred that the aliphatic carboxylic acid is linear and saturated.
- the polymeric biguanide is PHMB.
- the organic acid salts of the polymeric biguanide exhibit antimicrobial, especially antibacterial, activity. Consequently, the polymeric biguanide salts or compositions containing the polymeric biguanide salts may be used to protect various media from microbiological growth.
- the medium may be an industrial medium such as a cooling water tower liquid, paper mill liquor, metal working fluid, geological drilling lubricant, polymer emulsion, surface coating composition such as paint, varnish or lacquer.
- the medium to be protected can be a solid such as wood or leather and particularly solid surfaces in the health-care or food preparation industries.
- the solid may also be a textile material such as cellulose, including its blends with synthetic polymers and also non-woven materials such as those used in disposable items such as nappies, incontinence pads and feminine hygiene packs.
- the polymeric biguanide salt may be applied by any method known to the art such as spraying, dipping or coating with a composition containing the polymeric biguanide salt.
- the amount of polymeric biguanide salt which is applied to the medium to be protected from microbiological growth may be just sufficient to inhibit such growth or it may be in -excess of such amount.
- the amount of polymeric biguanide salt which is applied to such medium is not greater than 2% and more preferably not greater than 1% by weight of the medium.
- adequate protection is provided by from 1 ppm to 500 ppm, particularly 10 to 200 ppm and especially 10 to 100 ppm of the polymeric biguanide salt relating to the medium.
- the product was obtained as a paste containing 11.0 Kgm PHMB stearate (50% theory).
- the PHMB stearate salt exhibited similar microbiological activity to the hydrochloride salt when allowance is made for the different molecular weights.
- Palmitic acid (1.35 parts ex Aldrich) were dissolved in water (15 ml) by heating to 60° C. and adjusting the pH value to between 9 and 10 by adding caustic soda.
- PHMB hydrochloride (1 part as 20% solution, Cosmocil CQ ex Zeneca) was added and the reactants stirred at 80° C. for 2 hours. The reaction mass was then cooled to 20° C. whereupon the PHMB palmitate separated as a clear gum (1.86 parts).
- Example 2 was repeated except replacing the palmitic acid with an equivalent amount of lauric acid and octanoic acid, respectively.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Environmental Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
A composition comprising a carrier and a polymeric biguanide in the form of its salt with an organic acid containing from 4 to 30 carbon atoms such as poly (hexamethylenebiguanide) stearate.
Description
- The present invention relates to organic acid salts of polymeric biguanides, to compositions thereof, and their use as an industrial biocide or in personal care applications.
- Poly(hexamethylenebiguanide) (hereinafter PHMB) has found many uses as a broad spectrum bactericide in both industrial and personal care applications and is commercially available as an aqueous concentrate of its hydrochloride salt. For most applications, the use of PHMB in the form of its hydrochloride salt is eminently suitable. However, there exist some applications where the presence of chloride ion can cause undesirable side effects such as corrosion of metal surfaces. GB 1,464,005 discloses that other salts of PHMB may be used as molluscicides, such as sulphate, acetate, gluconate and behenate. However, no microbiological data is recorded for such salts. Behenic acid is an aliphatic carboxylic acid containing a C21-alkyl chain and falls within the group, anionic surfactants. The concentrated aqueous solution of PHMB in the form of its hydrochloride salt is clearly stated to be incompatible with anionic surfactants, alkyl sulphonates and anionic caramels as disclosed in the Product Information Notes for Vantocil IB (37-8E dated Jun. 1, 1994) and Cosmocil CQ (37-26E dated Apr. 1, 1994). Both Vantocil and Cosmocil are registered trade marks of Zeneca Specialties.
- Bisbiguanides have also been made available commercially as water-soluble salts such as chlorhexidine (1,1′-hexamethylene bis[5-(4-chlorophenyl)-biguanide]digluconate) and alexidine (1,1′-hexamethylene bis [5-(4-(2-ethylhexyl)phenyl)-biguanide]-diacetate). These water-soluble salts and PHMB hydrochloride are not particularly suited to provide a solution of the polymeric biguanide in organic liquids, especially non-polar organic liquids.
- It has now been found that PHMB in the form of its salt of an organic acid containing from 4 to 30 carbon atoms exhibits high antimicrobial, especially antibacterial activity, and that such salts exhibit increased solubility in organic media, especially organic liquids.
- According to the present invention there is provided a composition comprising a carrier and a polymeric biguanide in the form of its salt with an organic acid containing from 4 to 30 carbon atoms, including mixtures thereof.
-
- Preferably, the polymeric biguanide contains at least two biguanide units of Formula 1 which are linked by a bridging group which contains at least one methylene group. The bridging group may include a polymethylene chain which may optionally be interrupted by hetero atoms such as oxygen, sulphur or nitrogen. The bridging group may include one or more cyclic nuclei which may be saturated or unsaturated. Preferably, the bridging group is such that there are at least three, and especially at least four, carbon atoms directly interposed between two adjacent biguanide units of Formula 1. Preferably, there are not greater than ten and especially not greater than eight carbon atoms interposed between two adjacent biguanide units of Formula 1.
-
- When the terminating group is a hydrocarbyl group, it may be alkyl, cycloalkyl or aralkyl.
- When the terminating group is a substituted hydrocarbyl group, the substituent may be any substituent that does not exhibit an undesirable adverse effect on the microbiological properties of the polymeric biguanide. Examples of such substituents or substituted hydrocarbyl groups are aryloxy, alkoxy, acyl, acyloxy, halogen and nitrile.
- When the polymeric biguanide contains two biguanide groups of Formula 1, the two biguanide units are preferably linked by a polymethylene group, especially a hexamethylene group. The terminating groups in such polymeric biguanides are preferably 4-chlorophenyl or 2-ethylhexyl. Examples of such compounds are represented by Formulae 2 and 3 in their free base form
-
- wherein X and Y may be the same or different and represent bridging groups in which, together, the total number of carbon atoms directly interposed between the pairs of nitrogen atoms linked by X and Y is not less than 9 and not greater than 17.
- The bridging groups X and Y may consist of a polymethylene chain, optionally interrupted by a heteroatom such as oxygen, sulphur or nitrogen. X and Y may also incorporate a cyclic nucleus which may be saturated or unsaturated, wherein the number of carbon atoms directly interposed between the pairs of nitrogen atoms linked by X and Y is taken as including that segment of the cyclic group, or groups, which is the shortest. Thus, the number of carbon atoms directly interposed between the nitrogen atoms in the group
- is 4 and not 8.
- The preferred polymeric biguanide for use in the present invention is poly(hexamethylenebiguanide), in which both X and Y in Formula 4 are the group —(CH2)6+
-
- is, together, from 3 to about 80.
-
- wherein the value of n is from 4 to 40 and especially from 4 to 15. It is particularly preferred that the average value of n in the mixture is 12. Preferably, the average molecular weight of the polymer mixture is from 1100 to 3300.
- The organic acid which forms the salt with the polymeric biguanide may contain a phosphonic, phosphoric, sulphonic or sulphate group but preferably contains a carboxylic acid group. The organic acid may be aromatic but is preferably aliphatic, including alicyclic. When the organic acid is aliphatic, the aliphatic chain of the organic acid may be linear or branched, saturated or unsaturated, including mixtures thereof. Preferably, the aliphatic chain is linear and it is also preferred that the organic acid is an aliphatic carboxylic acid.
- It is preferred that the organic acid contains not less than eight, more preferably not less than ten and especially not less than twelve carbon atoms excluding the acid group. Preferably, the organic acid contains not greater than 24, more preferably not greater than 20 and especially not greater than 18 carbon atoms excluding the acid group.
- The organic acid may contain more than one acid group but it is preferred that only one such group is present.
- The organic acid may be substituted by a halogen or particularly hydroxy group. It is, however, preferred that the organic acid is free from substituents.
- Some aliphatic carboxylic acids are available commercially as mixtures such as those obtained from animal fats and vegetable oils and these contain both saturated and unsaturated aliphatic chains. These have also been found useful, especially the C14-18-alkyl carboxylic acids and their fully saturated or hydrogenated analogues.
- Examples of optionally substituted carboxylic acids are valeric, hexanoic, octanoic, 2-octenoic, lauric, 5-dodecenoic, myristic, pentadecanoic, palmitic, oleic, stearic, eicosanoic, heptadecanoic, palmitoleic, ricinoleic, 1 2-hydroxystearic, 16-hydroxyhexadecanoic, 2-hydroxycaproic, 1 2-hydroxydodecanoic, 5-hydroxydodecanoic, 5-hydroxydecanoic, 4-hydroxydecanoic, dodecanedioic, undecanedioic, sebacic, benzoic, hydroxbenzoic and teraphthalic acids.
- Particularly useful effects have been obtained when the aliphatic carboxylic acid is stearic acid and the polymeric biguanide is PHMB.
- The carrier may be a solid but is preferably a liquid.
- The liquid may be water whereby the composition containing the organic acid is a dispersion or emulsion. Preferably, the aqueous composition also contains a surfactant, particularly a non-ionic surfactant such as a polyalkylene oxide and especially an ethoxylate. The aqueous composition may also contain other adjuvents which help distribute the polymeric biguanide salt uniformly throughout the composition. Examples of such adjuvants are compounds which provide structure to the water to inhibit sedimentation such as alginates and gums, particularly Xanthan gum.
- When the carrier is a liquid it is preferably a polar organic liquid, a substantially non-polar organic liquid or a halogenated hydrocarbon. By the term “polar” in relation to the organic liquid is meant an organic liquid or resin capable of forming moderate to strong bonds as described in the article entitled “A Three Dimensional Approach to Solubility” by Crowley et al in Journal of Paint Technology, Vol. 38, 1966, at page 269. Such organic liquids generally have a hydrogen bonding number of 5 or more as defined in the abovementioned article.
- Examples of suitable polar organic liquids are amines, ethers, especially lower alkyl ethers, organic acids, esters, ketones, glycols, alcohols and amides. Numerous specific examples of such moderately strongly hydrogen bonding liquids are given in the book entitled “Compatibility and Solubility” by Ibert Mellan (published in 1968 by Noyes Development Corporation) in Table 2.14 on pages 3940 and these liquids all fall within the scope of the term polar organic liquid as used herein.
- Preferred polar organic liquids are dialkyl ketones, alkyl esters of alkane carboxylic acids and alkanols, especially such liquids containing up to, and including, a total of 6 carbon atoms. As examples of the preferred and especially preferred liquids there may be mentioned dialkyl and cycloalkyl ketones, such as acetone, methyl ethyl ketone, diethyl ketone, di-isopropyl ketone, methyl isobutyl ketone, di-isobutyl ketone, methyl isoamyl ketone, methyl n-amyl ketone and cyclohexanone; alkyl esters such as methyl acetate, ethyl acetate, isopropyl acetate, butyl acetate, ethyl formate, methyl propionate, methoxy propylacetate and ethyl butyrate; glycols and glycol esters and ethers, such as ethylene glycol, 2-ethoxyethanol, 3-methoxypropylpropanol, 3-ethoxypropylpropanol, 2-butoxyethyl acetate, 3-methoxypropyl acetate, 3-ethoxypropyl acetate and 2-ethoxyethyl acetate; alkanols such as methanol, ethanol, n-propanol, isopropanol, n-butanol and isobutanol and dialkyl and cyclic ethers such as diethyl ether and tetrahydrofuran.
- The substantially non-polar, organic liquids which may be used, either alone or in admixture with the aforementioned polar liquids, are aliphatic and aromatic hydrocarbons, such as toluene and xylene, and halogenated aliphatic and aromatic hydrocarbons, such as trichloro-ethylene, perchloroethylene and chlorobenzene.
- The organic acid salt of the polymeric biguanide may be made by any method known to the art but is preferably made by precipitation of the biguanide from aqueous solution by addition of the organic acid under alkaline conditions. The organic acid salts of the biguanide may be further purified by dissolution in a suitable organic liquid which is preferably immiscible with water and washing the organic phase with water to remove any residual water soluble salts.
- The amount of polymeric biguanide in the composition may vary between wide limits depending on its end usage. Thus, where the composition is used to confer antimicrobial protection to a medium which is to be protected against microbiological spoilage the amount of polymeric biguanide may be just sufficient to provide such protection. Preferably the amount of biguanide is not less than 1 ppm, more preferably not less than 10 ppm and especially not less than 20 ppm. It will be appreciated that where the composition containing the salt of the polymeric biguanide is to be transported in bulk the amount of the polymeric biguanide salt is as high as possible provided that the biguanide salt remains uniformly distributed throughout the composition. Preferably, the amount of polymeric biguanide salt in the composition is not greater than 30%, more preferably not greater than 25% and especially not greater than 20% based on the total weight of the composition.
- Some of the polymeric biguanides in the form of a salt with an organic acid containing from 4 to 30 carbon atoms are novel. Thus, according to a further aspect of the invention there is provided a polymeric biguanide in the form of a salt with an aliphatic carboxylic acid containing from 4 to 20 carbon atoms, particularly from 10 to 20 carbon atoms and especially from 12 to 18 carbon atoms excluding the —COOH group, optionally substituted by hydroxy.
- It is particularly preferred that the aliphatic carboxylic acid is free from substituents.
- The aliphatic carboxylic acid may be linear or branched, saturated or unsaturated, including mixtures thereof. It is preferred that the aliphatic carboxylic acid is linear and saturated.
- It is especially preferred that the polymeric biguanide is PHMB.
- As noted hereinbefore, the organic acid salts of the polymeric biguanide exhibit antimicrobial, especially antibacterial, activity. Consequently, the polymeric biguanide salts or compositions containing the polymeric biguanide salts may be used to protect various media from microbiological growth.
- According to a still further aspect of the invention there is provided a method for inhibiting microbiological growth on, or in a medium which comprises treating the medium with a polymeric biguanide in the form of its salt with an organic acid containing from 4 to 30 carbon atoms. The polymeric biguanide salt can be used in any conditions in which micro-organisms grow and cause problems. Thus, the medium may be an industrial medium such as a cooling water tower liquid, paper mill liquor, metal working fluid, geological drilling lubricant, polymer emulsion, surface coating composition such as paint, varnish or lacquer. The medium to be protected can be a solid such as wood or leather and particularly solid surfaces in the health-care or food preparation industries. The solid may also be a textile material such as cellulose, including its blends with synthetic polymers and also non-woven materials such as those used in disposable items such as nappies, incontinence pads and feminine hygiene packs.
- Where the medium to be protected is a solid, the polymeric biguanide salt may be applied by any method known to the art such as spraying, dipping or coating with a composition containing the polymeric biguanide salt.
- As noted hereinbefore, the amount of polymeric biguanide salt which is applied to the medium to be protected from microbiological growth may be just sufficient to inhibit such growth or it may be in -excess of such amount. Preferably, the amount of polymeric biguanide salt which is applied to such medium is not greater than 2% and more preferably not greater than 1% by weight of the medium. Generally, adequate protection is provided by from 1 ppm to 500 ppm, particularly 10 to 200 ppm and especially 10 to 100 ppm of the polymeric biguanide salt relating to the medium.
- The invention is illustrated by the following examples wherein all parts and percentages are references to weight unless indicated to the contrary.
- Water (150 litres) was added to a reactor vessel followed by stearic acid (14.8 Kgm, 0.047M). Sodium hydroxide flake (1.88 Kgm, 0.047M) was added with stirring, giving a pH value in the range 9.0 to 10.0. PHMB hydrochloride (50 litres as 20% aqueous solution, 0.047M, Vantocil IB ex. Zeneca) was added and the reactants stirred at 80° C. for 2 hours. After cooling, the PHMB stearate salt was separated on a slurry filter, washed with water and dried.
- The product was obtained as a paste containing 11.0 Kgm PHMB stearate (50% theory).
- The PHMB stearate salt exhibited similar microbiological activity to the hydrochloride salt when allowance is made for the different molecular weights.
- Palmitic acid (1.35 parts ex Aldrich) were dissolved in water (15 ml) by heating to 60° C. and adjusting the pH value to between 9 and 10 by adding caustic soda. PHMB hydrochloride (1 part as 20% solution, Cosmocil CQ ex Zeneca) was added and the reactants stirred at 80° C. for 2 hours. The reaction mass was then cooled to 20° C. whereupon the PHMB palmitate separated as a clear gum (1.86 parts).
- Example 2 was repeated except replacing the palmitic acid with an equivalent amount of lauric acid and octanoic acid, respectively.
- The MIC values for the different salts of poly(hexamethylene biguanide) were determined by dissolving the salts in methanol/dimethylformamide (1:6). The results are given in Table 1 below and show that the different salts exhibit similar antimicrobial activity against yeast and bacteria.
TABLE 1 Example Anion C. albicans E.coli St. aureus 5 stearate 100 2.3 3.1 6 palmitate 150 4.7 4.7 7 octanoate >150 0.8 2.3 8 laurate >150 1.2 1.2 9 chloride (D) >150 0.8 1.2 10 chloride (W) >150 0.4 1.6 11 stearate (M) >150 2.3 3.1
Claims (14)
1. A composition comprising a carrier and a linear polymeric biguanide which has a recurring polymeric unit represented by formula 4 in the form of its salt with an organic acid containing from 4 to 30 carbon atoms which is optionally substituted by a halogen or a hydroxy group, including salts thereof
wherein x and y may be the same or different and represent bridging groups in which together, the total number of carbon atoms directly interposed between the pairs of nitrogen atoms linked by x and y is not less than 9 and not greater than 17.
2. A composition as claimed in claim 1 wherein both X and Y is the group —(CH2)6—.
4. A composition as claimed in any one of claims 1 to 3 wherein the organic acid contains a carboxylic acid group.
5. A composition as claimed in any one of claims 1 to 4 wherein the organic acid contains not less than 8 carbon atoms.
6. A composition as claimed in any one of claims 1 to 5 wherein the organic acid contains from 12 to 18 carbon atoms.
7. A composition as claimed in any one of claims 1 to 6 wherein the organic acid is free from substituents.
8. A composition as claimed in any one of claims 1 to 4 wherein the organic acid is selected from valeric, hexanoic, octanoic, 2-octenoic, lauric, 5-dodecenoic, myristic, oentadecanoic, palmitic, oleic, stearic, eicosanoic, heptadecanoic, palmitoleic, ricinoleic 12-hydroxystearic, 16-hydroxyhexadecanoic, 2-hydroxycaproic, 12-hydroxydodecanoic, 5-hydroxydodecanoic, 5-hydroxydecanoic, 4-hydroxydecanoic, dodecanedioic, undecanedioic, sebacic, benzoic, hydroxbenzoic and teraphthalic acids.
9. A composition as claimed in any one of claims 1 to 8 wherein the carrier is a polar organic liquid, a substantially non-polar organic liquid or a halogenated hydrocarbon.
10. A composition as claimed in claim 9 wherein the polar organic liquid is an alkanol.
11. A linear polymeric biguanide which has a recurring polymeric unit represented by formula 4 in the form of its salt with an unsubstituted aliphatic carboxylic acid containing from 4 to 20 carbon atoms excluding the acid group
wherein X and Y may be the same or different and represent bridging groups in which together, the total number of carbon atoms directly interposed between the pairs of nitrogen atoms linked by X and Y is not less than 9 and not greater than 17.
13. The salt of a polymeric biguanide as claimed in either claim 11 or claim 12 wherein the aliphatic acid is stearic acid.
14. A method for inhibiting microbiological growth on, or in, a medium which comprises treating the medium with a linear polymeric biguanide which has a recurring polymeric unit represented by formula 4 in the form of its salt with an organic acid containing from 4 to 30 carbon atoms which is optionally substituted by a halogen or a hydroxy group, including salts thereof
wherein X and Y may be the same or different and represent bridging groups in which together, the total number of carbon atoms directly interposed between the pairs of nitrogen atoms linked by X and Y is not less than 9 and not greater than 17.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9712317.8A GB9712317D0 (en) | 1997-06-13 | 1997-06-13 | Composition, compound and use |
GB9712317.8 | 1997-06-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020142020A1 true US20020142020A1 (en) | 2002-10-03 |
Family
ID=10814094
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/445,765 Abandoned US20020142020A1 (en) | 1997-06-13 | 1998-06-05 | Biocidal organic acid salts of a polymeric biguanide |
US09/094,324 Expired - Lifetime US6509022B2 (en) | 1997-06-13 | 1998-06-09 | Composition for use in personal care comprising organic acid salts of polymeric biguanidines |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/094,324 Expired - Lifetime US6509022B2 (en) | 1997-06-13 | 1998-06-09 | Composition for use in personal care comprising organic acid salts of polymeric biguanidines |
Country Status (22)
Country | Link |
---|---|
US (2) | US20020142020A1 (en) |
EP (2) | EP0987947B1 (en) |
JP (2) | JP4308331B2 (en) |
KR (1) | KR20010013704A (en) |
CN (2) | CN100577142C (en) |
AR (2) | AR012965A1 (en) |
AT (1) | ATE227932T1 (en) |
AU (2) | AU742600B2 (en) |
BR (2) | BR9810435B1 (en) |
CA (2) | CA2295012A1 (en) |
DE (2) | DE69817564T2 (en) |
ES (1) | ES2205509T3 (en) |
GB (1) | GB9712317D0 (en) |
HU (1) | HUP0003065A3 (en) |
ID (1) | ID24652A (en) |
IN (1) | IN190655B (en) |
NO (1) | NO996042L (en) |
NZ (1) | NZ501740A (en) |
PL (1) | PL188771B1 (en) |
RU (1) | RU2209620C2 (en) |
WO (2) | WO1998056252A1 (en) |
ZA (2) | ZA985030B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100075131A1 (en) * | 2008-09-19 | 2010-03-25 | Etzel Mark R | Ligand Graft Functionalized Substrates |
WO2011131773A1 (en) | 2010-04-23 | 2011-10-27 | Centre National De La Recherche Scientifique (C.N.R.S) | Novel antimicrobial composition, use and preparation thereof |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030147925A1 (en) * | 1998-09-11 | 2003-08-07 | Samuel P. Sawan | Topical dermal antimicrobial compositions, methods for generating same, and monitoring methods utilizing same |
US6294163B1 (en) | 1998-10-02 | 2001-09-25 | Geltex Pharmaceuticals, Inc. | Polymers containing guanidinium groups as bile acid sequestrants |
FR2827507B1 (en) * | 2001-07-18 | 2005-07-01 | Oreal | POLYGUANIDINE DERIVATIVE COMPOUND AND USE OF SUCH A COMPOUND FOR THE PROTECTION AND / OR CARE OF KERATIN FIBERS |
FR2830442B1 (en) * | 2001-10-09 | 2004-02-06 | Oreal | USE OF A POLYGUANIDINE COMPOUND FOR TREATMENT OR HAIR SHAPING, ESPECIALLY STRAIGHTENING OR PERMANENT |
ATE364684T1 (en) | 2001-10-09 | 2007-07-15 | Procter & Gamble | MOISTIFIED WIPE CONTAINING POLYMERIC BIGUANIDE COMPOUNDS FOR THE TREATMENT OF SURFACES |
FR2841778B1 (en) * | 2002-07-05 | 2004-10-01 | Oreal | USE OF A POLYGUANIDINE-DERIVED COMPOUND IN A COLOR TREATMENT |
US8795638B1 (en) * | 2003-08-26 | 2014-08-05 | Nevada Naturals Inc. | Compositions for dental care |
FR2860158A1 (en) * | 2003-09-30 | 2005-04-01 | Oreal | Foaming, cleaning composition containing a polyguanidine derivative, useful as cosmetic cleanser and for treating greasy skin, also contains at least one lathering surfactant |
RU2256439C1 (en) * | 2004-04-08 | 2005-07-20 | Генкин Дмитрий Дмитриевич | Formulation for facial skin washing |
DE102004037598A1 (en) * | 2004-08-03 | 2006-02-23 | Prontomed Gmbh | Medium, useful as mouth and throat rinsing solution or mouth spray, comprises microbicide aqueous solution comprising a linear biguanide polymer and/or water-soluble salt of microbicide in combination with a sweetener |
US20060272107A1 (en) * | 2005-05-17 | 2006-12-07 | Gerard Malle | Hair relaxing composition comprising at least one non-hydroxide polyguanidine |
US20060269498A1 (en) * | 2005-05-17 | 2006-11-30 | Gerard Malle | Hair shaping composition comprising at least one polyguanidine other than hydroxide |
FR2885902B1 (en) * | 2005-05-17 | 2008-05-09 | Oreal | HAIR REMOVAL COMPOSITION COMPRISING AT LEAST ONE NON-HYDROXIDE MULTIGUANIDINE |
FR2885800B1 (en) * | 2005-05-17 | 2008-05-09 | Oreal | HAIR FORMING COMPOSITION COMPRISING AT LEAST ONE NON-HYDROXIDE MULTIGUANIDINE |
EP1924298B1 (en) * | 2005-09-15 | 2010-07-14 | Aesculap AG | Biocompatible antimicrobial suture material |
KR20090075701A (en) * | 2006-10-27 | 2009-07-08 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | Antimicrobial compositions |
JP2011507978A (en) * | 2007-12-31 | 2011-03-10 | スリーエム イノベイティブ プロパティズ カンパニー | Antibacterial composition |
WO2009097467A2 (en) * | 2008-01-29 | 2009-08-06 | Tetsuo Nakatsu | A functional material and delivery gel composition and method for manufacturing the same |
TW201138843A (en) | 2009-12-18 | 2011-11-16 | Colgate Palmolive Co | Biguanide preservation of precipitated calcium carbonate |
PL2524705T3 (en) * | 2011-05-19 | 2014-12-31 | Lohmann & Rauscher Gmbh & Co Kg | Sterilized wound dressing comprising a triblock-elastomeric component and hydrophobic polymeric Biguanid |
US10289412B2 (en) * | 2012-02-09 | 2019-05-14 | Qualcomm Incorporated | Floating point constant generation instruction |
WO2013121407A1 (en) * | 2012-02-17 | 2013-08-22 | Budhi Haryanto | The composition of malodor removing aerosol for daily worn objects or items |
CN105315459B (en) * | 2014-10-29 | 2017-09-26 | 吉林云飞医药有限公司 | A kind of preparation method of polyadipate base guanidine hydrochloride |
CN109890354B (en) | 2016-10-24 | 2020-10-02 | 高露洁-棕榄公司 | Oral care compositions and methods of use |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB843676A (en) * | 1957-12-31 | 1960-08-10 | Ici Ltd | New biguanide salts |
BE698595A (en) * | 1966-05-23 | 1967-11-17 | ||
GB1434040A (en) * | 1973-08-06 | 1976-04-28 | Ici Ltd | Process for combating fungi and bacteria |
GB1464005A (en) * | 1974-04-22 | 1977-02-09 | Ici Ltd | Method for the destruction of aquatic molluscs |
LU74539A1 (en) * | 1976-03-12 | 1977-09-27 | ||
US4478821A (en) * | 1982-01-26 | 1984-10-23 | The Gillette Company | Inhibition of body odor |
JP2544388B2 (en) * | 1986-09-04 | 1996-10-16 | 株式会社 上野製薬応用研究所 | Virus inactivating agent |
AU633499B2 (en) * | 1988-06-30 | 1993-02-04 | Michael H. Davis | Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo |
US4954636A (en) * | 1989-07-03 | 1990-09-04 | Gaf Chemicals Corporation | Antimicrobial polymeric bisbiguanides |
US5268168A (en) * | 1990-02-19 | 1993-12-07 | Sakai Engineering Co., Ltd. | Antibacterial and deodorant processing agent and processing method using same |
ZA952521B (en) * | 1994-03-28 | 1996-03-15 | Univ Columbia | Composition for inactivating irritants in fluids |
JPH08119878A (en) * | 1994-10-19 | 1996-05-14 | Lion Corp | Antimicrobial agent and its production |
GB9726132D0 (en) | 1997-12-10 | 1998-02-11 | Unilever Plc | Deodorant composition |
-
1997
- 1997-06-13 GB GBGB9712317.8A patent/GB9712317D0/en active Pending
-
1998
- 1998-03-06 ID IDW991567A patent/ID24652A/en unknown
- 1998-06-03 RU RU2000100989/14A patent/RU2209620C2/en not_active IP Right Cessation
- 1998-06-03 DE DE69817564T patent/DE69817564T2/en not_active Expired - Lifetime
- 1998-06-03 WO PCT/EP1998/003492 patent/WO1998056252A1/en active IP Right Grant
- 1998-06-03 JP JP50160199A patent/JP4308331B2/en not_active Expired - Fee Related
- 1998-06-03 AU AU79192/98A patent/AU742600B2/en not_active Ceased
- 1998-06-03 ES ES98929439T patent/ES2205509T3/en not_active Expired - Lifetime
- 1998-06-03 PL PL98337277A patent/PL188771B1/en unknown
- 1998-06-03 HU HU0003065A patent/HUP0003065A3/en unknown
- 1998-06-03 CN CN98808095A patent/CN100577142C/en not_active Expired - Fee Related
- 1998-06-03 CA CA002295012A patent/CA2295012A1/en not_active Abandoned
- 1998-06-03 EP EP98929439A patent/EP0987947B1/en not_active Expired - Lifetime
- 1998-06-03 BR BRPI9810435-7A patent/BR9810435B1/en not_active IP Right Cessation
- 1998-06-03 NZ NZ501740A patent/NZ501740A/en not_active IP Right Cessation
- 1998-06-05 EP EP98925853A patent/EP0987946B1/en not_active Expired - Lifetime
- 1998-06-05 US US09/445,765 patent/US20020142020A1/en not_active Abandoned
- 1998-06-05 DE DE69809548T patent/DE69809548T2/en not_active Expired - Lifetime
- 1998-06-05 CN CN98806103A patent/CN1259846A/en active Pending
- 1998-06-05 WO PCT/GB1998/001662 patent/WO1998056253A1/en not_active Application Discontinuation
- 1998-06-05 KR KR1019997011719A patent/KR20010013704A/en not_active Withdrawn
- 1998-06-05 AU AU77825/98A patent/AU7782598A/en not_active Abandoned
- 1998-06-05 BR BR9810251-6A patent/BR9810251A/en not_active IP Right Cessation
- 1998-06-05 AT AT98925853T patent/ATE227932T1/en not_active IP Right Cessation
- 1998-06-05 JP JP50187899A patent/JP2002505695A/en active Pending
- 1998-06-05 CA CA002293558A patent/CA2293558A1/en not_active Abandoned
- 1998-06-09 US US09/094,324 patent/US6509022B2/en not_active Expired - Lifetime
- 1998-06-10 AR ARP980102760A patent/AR012965A1/en unknown
- 1998-06-10 ZA ZA9805030A patent/ZA985030B/en unknown
- 1998-06-11 IN IN359BO1998 patent/IN190655B/en unknown
- 1998-06-11 ZA ZA985096A patent/ZA985096B/en unknown
- 1998-06-12 AR ARP980102797A patent/AR015884A1/en active IP Right Grant
-
1999
- 1999-12-08 NO NO996042A patent/NO996042L/en not_active Application Discontinuation
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100075131A1 (en) * | 2008-09-19 | 2010-03-25 | Etzel Mark R | Ligand Graft Functionalized Substrates |
US20100075560A1 (en) * | 2008-09-19 | 2010-03-25 | Kannan Seshadri | Ligand Graft Functionalized Substrates |
US8551894B2 (en) * | 2008-09-19 | 2013-10-08 | 3M Innovative Properties Company | Ligand graft functionalized substrates |
US9302208B2 (en) | 2008-09-19 | 2016-04-05 | 3M Innovative Properties Company | Ligand graft functionalized substrates |
US9492771B2 (en) | 2008-09-19 | 2016-11-15 | 3M Innovative Properties Company | Ligand graft functionalized substrates |
WO2011131773A1 (en) | 2010-04-23 | 2011-10-27 | Centre National De La Recherche Scientifique (C.N.R.S) | Novel antimicrobial composition, use and preparation thereof |
EP2386589A1 (en) * | 2010-04-23 | 2011-11-16 | Centre National de la Recherche Scientifique (C.N.R.S) | Novel antimicrobial composition, use and preparation thereof |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20020142020A1 (en) | Biocidal organic acid salts of a polymeric biguanide | |
JP3939355B2 (en) | Synergistic fungicide composition containing ionene polymer and dodecylamine salt and method of use thereof | |
TW450786B (en) | Solid biocidal compositions | |
US7008531B2 (en) | Treatment of circulating water systems | |
AU2001292087B2 (en) | Method and compositions | |
EP0593250A1 (en) | Synergistic antimicrobial combination of polyether phosphonates and non-oxidizing biocides | |
JP5629905B2 (en) | Industrial fungicide | |
AU8595198A (en) | Composition for inhibiting microbial adhesion on surfaces | |
JPS5950642B2 (en) | industrial disinfectant | |
PL201886B1 (en) | Disinfectants | |
US5677345A (en) | Synergistic antimicrobial composition of N- (dichlorofluoromethyl)thio!-N',N'-dimethyl-N-phenylsulfamide and alkylguanidine compounds | |
EP1110454A2 (en) | 5-Carboxanilido-haloalkylthiazoles as antimicrobial and marine antifouling agents | |
EP0722658B1 (en) | Storage stable biocide composition and process for making the same | |
US20030032768A1 (en) | Double end-capped polymeric biguanides | |
CA2956308C (en) | Synergistic antimicrobial composition | |
JPS6344121B2 (en) | ||
US5663206A (en) | Synergistic antimicrobial composition of N-decyl-N-isononyl-N,N-dimethyl ammonium chloride and alkylguanidine compounds | |
EP0771527A1 (en) | Antimicrobial compounds with quick speed of kill | |
US5283264A (en) | Chemically stable antimicrobial formulations of dimps | |
DE2952167A1 (en) | NEW GUANIDINIUM COMPOUNDS, METHOD FOR THE PRODUCTION AND USE THEREOF AS A MICROBIOCIDE AGENT | |
US6214885B1 (en) | Use of polymers containing β-hydroxyalkylvinylamine units as biocides | |
JPH10139603A (en) | Industrial antibacterial agent | |
CA2053162A1 (en) | Admixtures of 2-bromo-2-bromomethylglutaronitrile and n,4-dihydroxy- -oxobenzene-ethanimidoyl chloride |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: AVECIA LIMITED, UNITED KINGDOM Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WOOLLVEN, PETER;REEL/FRAME:010559/0117 Effective date: 19991109 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |